Quarterly Results

  • Company Name :
Anthem Biosciences Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 544449
  • NSE Symbol:
  • ANTHEM
  • P/E(TTM):
  • 90.75
  • ISIN Demat:
  • INE0CZ201020
  • Div & Yield%:
  • -
  • EPS(TTM):
  • 9.02
  • Book Value(₹):
  • 44.05
  • Market Cap(₹Cr.):
  • 45,970.59
  • Face Value(₹):
  • 2.00
Quarters :  
Particulars June 2025 ( Cr)
Gross Sales 538.01
Excise Duty 0.00
Net Sales 538.01
Other Operating Income 0.00
Other Income 27.73
Total Income 565.74
Total Expenditure 342.58
PBIDT 223.16
Interest 1.61
PBDT 221.55
Depreciation 22.61
Tax 50.07
Fringe Benefit Tax 0.00
Deferred Tax 0.53
Reported Profit After Tax 148.34
Extra-ordinary Items 0.00
Adjusted Profit After Extra-ordinary item 148.34
EPS (Unit Curr.) 2.65
EPS (Adj) (Unit Curr.) 2.65
Calculated EPS (Unit Curr.) 2.65
Calculated EPS (Adj) (Unit Curr.) 2.65
Calculated EPS (Ann.) (Unit Curr.) 10.61
Calculated EPS (Adj) (Ann.) (Unit Curr.) 10.61
Book Value (Unit Curr.) 0.00
Dividend (%) 0.00
Equity 111.82
Reserve & Surplus 0.00
Face Value 2.00
Public Shareholding (No. Of Shares) 0.00
Public Shareholding (% in Equity) 0.00
Pledged/Encumbered - No. of Shares 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00
Pledged/Encumbered - % in Total Equity 0.00
Non Encumbered - No. of Shares 0.00
Non Encumbered - % in Total Promoters Holding 0.00
Non Encumbered - % in Total Equity 0.00
PBIDTM(%) 41.48
PBDTM(%) 41.18
PATM(%) 27.57